Kersia (Ardian-backed) Acquires Choisy Laboratories from Trudeau Family and Champlain Financial
July 18, 2019
Kersia, the Ardian-backed global leader in food safety and biosecurity, has acquired Choisy Laboratories Ltd., a Quebec-based developer and manufacturer of chemical, biotechnological and biosecurity hygiene solutions, from the Trudeau family and Champlain Financial Corporation for an undisclosed amount. The deal expands Kersia's North American footprint, adds Choisy's enzymatic and biotech capabilities, and brings c.250 employees and additional R&D and manufacturing capacity into the Kersia network.
- Buyers
- Kersia, Ardian
- Targets
- Choisy Laboratories Ltd.
- Sellers
- Trudeau family, Champlain Financial Corporation
- Platforms
- Kersia
- Industry
- Manufacturing
- Location
- Quebec, Canada
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
IK Investment Partners to Acquire Majority Stake in Kersia from Ardian
October 12, 2020
Manufacturing
IK Investment Partners' IK IX Fund has entered exclusive negotiations and allocated CSR-linked financing to acquire a majority stake in Kersia from Ardian. Kersia is a global leader in biosecurity and food safety with revenues above €300m, operations in 120+ countries and more than 1,500 employees; IK intends to support the company's next stage of growth and sustainability agenda.
-
Ardian Acquires Cérélia from IK Investment Partners
December 19, 2019
Food & Beverage
Ardian has agreed to acquire Cérélia, a Paris-headquartered producer of ready-to-bake dough, pancakes, crepes and cookies, from the IK VII Fund advised by IK Investment Partners. Management, led by Guillaume Réveilhac, will retain a meaningful stake alongside Ardian as the buyer seeks to accelerate Cérélia's organic growth, acquisitions and geographic expansion across Europe and North America.
-
Laboratoires Lehning Acquires Laboratoire Lescuyer from Abenex
October 1, 2020
Pharmaceuticals
Groupe Lehning (Laboratoires Lehning) has acquired French dietary-supplements maker Laboratoire Lescuyer from private equity firm Abenex; Abenex and co-investors Bpifrance and Ouest Croissance sold their entire stakes. Isabelle de Carmantrand and the Lescuyer family reinvested alongside the buyer; the deal is intended to combine complementary therapeutic areas and distribution channels to accelerate brand growth.
-
Kaiterra Acquires ChemiSense
April 29, 2020
Environmental Services
Kaiterra, a global air quality device and data company headquartered in Crans-Montana, Switzerland, has acquired Berkeley, California-based ChemiSense. The acquisition expands Kaiterra’s product portfolio and distribution channels for commercial, industrial and residential air quality monitoring—initially strengthening its U.S. West Coast presence and adding ChemiSense’s sensor hardware and software capabilities.
-
Crown Laboratories Acquires Keri Brand from GlaxoSmithKline
May 1, 2019
Consumer Products
Crown Laboratories acquired the North American rights to the Keri skin care brand from GlaxoSmithKline and concurrently received an equity investment from Greenspring Associates. Existing investors Hildred Capital Partners and Montreux Equity Partners provided financing in connection with the transaction; financial terms were not disclosed.
-
Verdesian Life Sciences Acquires Cytozyme Laboratories
April 27, 2021
Agriculture
Verdesian Life Sciences has acquired Cytozyme Laboratories, Inc.; Cascadia Capital served as exclusive financial advisor to Cytozyme. The acquisition brings together complementary biological and nutritional crop technologies to expand Verdesian's product portfolio and support sustainable yield solutions for growers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.